# Insider Monkey

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/insider-monkey
Canonical HTML page: https://gethealthbrief.com/entity/insider-monkey

## Recent coverage (1 stories)

### CyPath Lung Test Volume Up 216% as bioAffinity Adds Surveillance Use
2026-09-05 14:59:30 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

bioAffinity's CyPath Lung test volume grew 216% year over year, and the company is now expanding into post-treatment surveillance for lung-cancer patients. The move could widen the test's clinical role beyond initial diagnostic decisions.
Full story: https://gethealthbrief.com/story/cypath-lung-surveillance-volume-growth-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.